Skip to main content
OpenTrials
Completed

NCT Number: NCT01943747

International Multicentre Prevalence Study on Sepsis

To mark 10 years of the Surviving Sepsis Campaign (SSC), and timed to coincide with World Sepsis Day, on September 13, 2013, the SSC, ESICM and SCCM will be conducting an international point prevalence study of severe sepsis and septic shock. The goal of this project is to determine the world wide burden of severe sepsis and define current practices of sepsis care internationally. The study is a simple data collection exercise for patients presenting with either severe sepsis or septic shock on World Sepsis Day.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Severe Sepsis Infections Inflammation Pathologic Processes Pathological Conditions, Signs and Symptoms Sepsis Septic Shock Shock Shock, Septic Systemic Inflammatory Response Syndrome

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

All centres willing to contribute are welcome.

Brussels, Belgium

About this study

De---identified patient---level data will be collected on patients presenting to a participating intensive care unit or emergency department with severe sepsis or septic shock over a 24 hour period from 00:00 to 24:00 November 07, 2013. De---identified data that is already collected as part of routine clinical care will be collected for this study. Data to be collected includes hospital and ICU characteristics, patient characteristics, severity of illness, and adherence to SSC bundle elements and mortality. It will take between 30---60 minutes to collect and enter data for each patient admitted with severe sepsis or septic shock over the 24 hours study period.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

To be eligible patients must have all of the following:

  • Must be admitted or transferred to either the ED or an Intensive Care Unit.
  • Have a high clinical suspicion of an infection
  • Have sepsis as defined by an infection together with two or more SIRS criteria
  • Evidence of acute organ dysfunction and/or Shock.

Exclusion criteria

  • Patients less than 18 years of age
  • Patients in whom the sepsis has been present from before the beginning of the study period
  • Any patients previously included in the study during the same study period

Treatment and study plan

Primary outcomes

  1. 28-Day Mortality

    Time frame: one week

Secondary outcomes

  1. Organ Failure

    Time frame: one week

Other outcomes

  1. Length of Stay in the Hospital

    Time frame: one week

Sponsors and collaborators

Lead sponsor

European Society of Intensive Care Medicine

Other

Collaborators

  • Society of Critical Care Medicine (SCCM)

Registry information

Official study title

Surviving Sepsis Campaign. International Multicentre Prevalence Study on Sepsis.

Acronym: IMPRESS

Important dates

Study start
2013
Primary completion
2013
Study completion
2014
First posted
Sep 17, 2013
Registry last updated
Aug 20, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.